By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein
Perhaps the greatest heights of the biopharma sector will never be seen again — but don’t overlook the good ti mes now. Th at is the central message in the following interview with Peter Meath, who heads the Life Science Group at J.P. Morgan’s Commercial Banking business. Meath also comments on the current industry environment and offers seasoned advice to novice entrepreneurs for turning a company’s novel science into a viable business.